Cardinal Health (CAH) Q1 FY2027 revenue $67.5 billion vs $67.3 billion est.; adj. EPS $3.26 vs $2.97 est.; raises guidance
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Cardinal Health reported fiscal first-quarter revenue of $67.5 billion, up 5% year over year and slightly above the $67.3 billion consensus, while adjusted diluted EPS rose 28% to $3.26, beating the $2.97 estimate. GAAP operating earnings increased 13% to $753 million and GAAP diluted EPS climbed 27% to $2.38, with non-GAAP operating earnings up 17% to $1.0 billion. The company raised its full-year guidance, though the article excerpt did not specify the new figures. The beat and guidance raise matter because they signal stronger-than-expected momentum in Cardinal's core distribution business. Investors will watch for the specific updated full-year EPS and revenue ranges, plus any commentary on drug pricing and segment margins.
Muhabbit's AI wrote this summary in its own words from PR Newswire's report. It can get details wrong, so check the source.
Named in this story
A linked name opens that asset's sentiment page.